# C_2022458EN.01001301.xml

| 1.12.2022 | EN | Official Journal of the European Union | C 458/13 |
| --- | --- | --- | --- |

1.12.2022

EN

Official Journal of the European Union

C 458/13

---

Prior notification of a concentration

(Case M.10874 – DSM / FONTERRA / TASMAN)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 458/09)

1.

This notification concerns the following undertakings:

| — | DSM Venturing B.V. (‘DSM’, The Netherlands), ultimately controlled by Royal DSM N.V. group (‘Royal DSM’, The Netherlands), |
| --- | --- |

—

DSM Venturing B.V. (‘DSM’, The Netherlands), ultimately controlled by Royal DSM N.V. group (‘Royal DSM’, The Netherlands),

| — | Fonterra (Europe) Coöperatie U.A. (‘Fonterra’, The Netherlands), ultimately controlled by Fonterra Co-operative Group Limited (‘Fonterra Co-operative’, New Zealand), |
| --- | --- |

—

Fonterra (Europe) Coöperatie U.A. (‘Fonterra’, The Netherlands), ultimately controlled by Fonterra Co-operative Group Limited (‘Fonterra Co-operative’, New Zealand),

| — | A newly created company, Tasman (‘JV’, The Netherlands). |
| --- | --- |

—

A newly created company, Tasman (‘JV’, The Netherlands).

DSM and Fonterra will acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of the JV.

The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.

2.

| — | Fonterra is active in the production and sale of dairy products worldwide, |
| --- | --- |

—

Fonterra is active in the production and sale of dairy products worldwide,

| — | DSM is active in nutrition, health and bioscience providing nutritional solutions, specialty additives to nutritional segments, ingredients, biomedical materials as well as solutions that address taste and texture, |
| --- | --- |

—

DSM is active in nutrition, health and bioscience providing nutritional solutions, specialty additives to nutritional segments, ingredients, biomedical materials as well as solutions that address taste and texture,

| — | The JV will be active in the market for alternative proteins by developing and producing, marketing and selling fermentation-derived dairy protein. |
| --- | --- |

—

The JV will be active in the market for alternative proteins by developing and producing, marketing and selling fermentation-derived dairy protein.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10874 – DSM / Fonterra / Tasman

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---